Australia markets close in 3 hours 7 minutes

Addex Therapeutics Ltd (ADXN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.85+0.44 (+4.68%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.41
Open9.56
Bid9.00 x 1200
Ask10.60 x 900
Day's range9.56 - 9.90
52-week range8.88 - 37.52
Volume7,613
Avg. volume5,573
Market cap71.531M
Beta (5Y monthly)1.42
PE ratio (TTM)N/A
EPS (TTM)-2.61
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric Modulators - Indivior Commits $4 Million of New Funding
    GlobeNewswire

    Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric Modulators - Indivior Commits $4 Million of New Funding

    IND enabling studies with Indivior collaboration drug candidate and separate Addex program scheduled for 2022 Geneva, Switzerland, July 29, 2021 (GLOBE NEWSWIRE) - Ad Hoc Announcement Pursuant to Art. 53 LR Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has extended its research collaboration agreement with Indivior PLC (LON: INDV). As part of the extension, Indi

  • Addex Therapeutics (ADXN) Sees Hammer Chart Pattern: Time to Buy?
    Zacks

    Addex Therapeutics (ADXN) Sees Hammer Chart Pattern: Time to Buy?

    Addex Therapeutics (ADXN) has been struggling lately, but the selling pressure may be coming to an end soon.

  • Addex Therapeutics to Present at Access to Giving Virtual Conference  on July 14, 2021
    GlobeNewswire

    Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021

    Geneva, Switzerland, July 7, 2021 - Addex Therapeutics (SIX:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Chief Executive Officer, Tim Dyer, will present at Access to Giving Virtual Conference at 9 AM ET on July 14, 2021. Mr. Dyer will give a corporate update, including an overview of recent advances in Addex’s clinical trial program. The conference is free to all registrants. Registration DetailsDate: W